Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Correlation of Physical Activities and Breast Cancer Characteristics: A Prospective Analysis with Special Focus on Triple Negative Breast Cancer.
Vallard A, Falk AT, Antoine P, Guy JB, Guichard JB, Espenel S, Langrand-Escure J, Trone JC, Méry B, Ben Mrad M, Diao P, Wang G, Roche F, Bosacki C, Chargari C, Bourmaud A, Magné N. Vallard A, et al. Among authors: ben mrad m. Oncology. 2015;89(5):262-8. doi: 10.1159/000437229. Epub 2015 Aug 19. Oncology. 2015. PMID: 26303109
Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation.
Wahart A, Guy JB, Vallard A, Geissler B, Ben Mrad M, Falk AT, Prevot N, de Laroche G, Rancoule C, Chargari C, Magné N. Wahart A, et al. Among authors: ben mrad m. Br J Radiol. 2016;89(1058):20150579. doi: 10.1259/bjr.20150579. Epub 2015 Dec 9. Br J Radiol. 2016. PMID: 26648528 Free PMC article.
Intensity-modulated radiotherapy or volumetric-modulated arc therapy in patients with head and neck cancer: Focus on salivary glands dosimetry.
Vallard A, Guy JB, Mengue Ndong S, Vial N, Rivoirard R, Auberdiac P, Méry B, Langrand-Escure J, Espenel S, Moncharmont C, Ben Mrad M, Diao P, Goyet D, Magné N. Vallard A, et al. Among authors: ben mrad m. Head Neck. 2016 Jul;38(7):1028-34. doi: 10.1002/hed.24398. Epub 2016 Feb 8. Head Neck. 2016. PMID: 26855006
Thirty years of phase I radiochemotherapy trials: Latest development.
Rivoirard R, Vallard A, Langrand-Escure J, Ben Mrad M, Wang G, Guy JB, Diao P, Dubanchet A, Deutsch E, Rancoule C, Magne N. Rivoirard R, et al. Among authors: ben mrad m. Eur J Cancer. 2016 May;58:1-7. doi: 10.1016/j.ejca.2016.01.012. Epub 2016 Feb 23. Eur J Cancer. 2016. PMID: 26922167 Review.
Safety assessment of molecular targeted therapies in association with radiotherapy in metastatic renal cell carcinoma: a real-life report.
Langrand-Escure J, Vallard A, Rivoirard R, Méry B, Guy JB, Espenel S, Trone JC, Ben Mrad M, Diao P, Rancoule C, Suchaud JP, Fournel P, Guillot A, Chargari C, Escudier B, Négrier S, Magné N. Langrand-Escure J, et al. Among authors: ben mrad m. Anticancer Drugs. 2016 Jun;27(5):427-32. doi: 10.1097/CAD.0000000000000349. Anticancer Drugs. 2016. PMID: 27045782
[50th anniversary of cisplatin].
Rancoule C, Guy JB, Vallard A, Ben Mrad M, Rehailia A, Magné N. Rancoule C, et al. Among authors: ben mrad m. Bull Cancer. 2017 Feb;104(2):167-176. doi: 10.1016/j.bulcan.2016.11.011. Epub 2016 Dec 15. Bull Cancer. 2017. PMID: 27989629 Review. French.
Lysophosphatidic acid (LPA) as a pro-fibrotic and pro-oncogenic factor: a pivotal target to improve the radiotherapy therapeutic index.
Rancoule C, Espenel S, Trone JC, Langrand-Escure J, Vallard A, Rehailia-Blanchard A, El Meddeb Hamrouni A, Xia Y, Guy JB, Ben-Mrad M, Magné N. Rancoule C, et al. Among authors: ben mrad m. Oncotarget. 2017 Jun 27;8(26):43543-43554. doi: 10.18632/oncotarget.16672. Oncotarget. 2017. PMID: 28402936 Free PMC article. Review.
97 results